跳至主要内容
临床试验/CTRI/2023/10/058425
CTRI/2023/10/058425尚未招募不适用

Role of Homoeopathic Medicines in case of Insomnia

DR HIREN D PARMAR1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年12月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
1. REDUCTION IN SYMPTOMS OF INSOMNIA.

研究概览

简要总结

Cases of Insomnia selected upon the basis of inclusion and exclusion criteria are administered with the Individualized Homoeopathic Medicines based upon the principles of Homoeopathy. This study aims to assess the utility of a Homoeopathic medicine for treating cases of insomnia. This study will demonstrate statistically significant improvement in sleep, as measured by validated sleep assessment scale,i.e, INSOMNIA SEVERITY INDEX. We hypothesize that these improvements will be associated with reduced insomnia and enhanced daytime functioning among individuals with Insomnia.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • DSM-5 will be used for the diagnostic criteria of the case.
  • Cases of pre diagnosed or with clinical presentation of insomnia will be selected.

排除标准

  • Cases having clinically gross pathological changes.
  • Cases with irregular follow up.
  • Pregnant women and lactating mother.

结局指标

主要结局

1. REDUCTION IN SYMPTOMS OF INSOMNIA.

时间窗: 15 DAYS

2. IMPROVEMENT IN DAY TIME FUNCTIONING.

时间窗: 15 DAYS

次要结局

  • 1. REDUCTION IN INSOMNIA SEVERITY EVALUATED THROUGH INSOMNIA SEVERITY INDEX.(2. EVALUATE THE EFFECTIVENESS OF HOMOEOPATHIC MEDICINES IN CASES OF INSOMNIA.)

研究者

发起方
DR HIREN D PARMAR
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验